BDBM762928 (2S,3S,4S,5R,6S)-6-((4-((1S,3S,5R)-3-Ethoxy-8-((5-methoxy-7-methyl-1H-indol-4-yl)m ethyl)-8-azabicyclo[3.2.1]octan-1-yl)benzoyl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid 5::US20250250267, Example 5

SMILES CCO[C@H]1C[C@H]2CC[C@](c3ccc(C(=O)O[C@@H]4O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]4O)cc3)(C1)N2Cc1c(OC)cc(C)c2[nH]ccc12

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 762928   

TargetComplement Factor B/C3(Human)
Jiangsu Hengrui Pharmaceuticals

US Patent
LigandPNGBDBM762928((2S,3S,4S,5R,6S)-6-((4-((1S,3S,5R)-3-Ethoxy-8-((5-...)
Affinity DataIC50: 30nMAssay Description:Cleavage reactions of the human complement factor B protein: The recombinant human complement factor D protein was diluted 10-fold with PBS (pH 7.4) ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/22/2025
Entry Details
US Patent